Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance

BACKGROUND: Prostate Cancer (PCa) is the second most prevalent cancer among U.S. males. In recent decades many men with low risk PCa have been over diagnosed and over treated. Given significant co-morbidities associated with definitive treatments, maximizing patient quality of life while recognizing...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Pestova, Katerina, Koch, Adam J., Quesenberry, Charles P., Shan, Jun, Zhang, Ying, Leimpeter, Amethyst D., Blondin, Beth, Sitailo, Svetlana, Buckingham, Lela, Du, Jing, Fei, Huixin, Van Den Eeden, Stephen K.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749018/
https://ncbi.nlm.nih.gov/pubmed/29291731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3910-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items